The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional)
The impact of pain on patient quality of life for diseases and conditions within the mission of the NIDDK is enormous. Despite prior research efforts, our understanding of the underlying biological and clinical contributors of pain remains limited. In addition, new clinical management strategies that better measure, predict, and target pain and improve upon current interventions, such as opioids, are critically needed. The current Funding Opportunity Announcement will address these needs through the invitation of broad investigator-initiated research projects proposing novel basic, translational, and clinical studies and efforts to develop new approaches to assess and treat pain for disorders within the NIDDK's mission. Investigations are expected to provide important new insights into the pathophysiology and clinical features of pain and foster new and improved treatment and pain management strategies for patients.
Letter of Intent: April 17, 2022 Application: May 17, 2022
RFA-DK-22-005 Expiration Date New Date March 18, 2022 per issuance of NOT-XX-XXX or FOA#. (Original Expiration Date: May 18, 2022 )
Application budgets may request a maximum of $750,000 direct costs per year. It is anticipated awards will be made through multi-year funding and encompass the approved total costs for the entire awarded project period. Funds beyond the first year will initially be restricted. Respective funds will be released each non-competing year per the terms of the Notice of Grant Award.
The maximum project period is 3 years.